Updates
Updated Investors' Presentation14-06-2017
Zydus Cadila gets USFDA nod to market ezetimibe tablets
Zydus Cadila has received approval from the US health regulator to market ezetimibe tablets used to treat high cholesterol. The company has received final approval from the USFDA to market...13-06-2017
Press Release
Zydus receives final approval from the USFDA for Ezetimibe Tablets USP; the drug is used to reduce high cholesterol levels13-06-2017
Zydus Cadila's Nesher Pharma gets USFDA nod for antifungal drug
Zydus Group firm Cadila Healthcare's subsidiary Nesher Pharma received nod from the USFDA to market Nystatin topical powder used for treating skin infections10-06-2017
Press Release
Zydus' Nesher Pharmaceuticals gets USFDA final approval for Nystatin Topical Powder10-06-2017
FDA nod for generic Lialda launch to boost US biz for Zydus Cadila in FY18
Market for the drug, which could be a key growth driver for firm's US business, is pegged at $1.1 bn07-06-2017
Cadila Healthcare hits fresh 52-week high
Shares of Cadila Healthcare hit their fresh 52-week high in early trade on Tuesday.06-06-2017
Zydus Cadila gets USFDA nod for anti-depressant
Drug firm Zydus Cadila has received the US Food and Drug Administration 's nod to market Mirtazapine, an anti-depressant, in the American market05-06-2017